<bill session="117" type="h" number="4418" updated="2022-12-31T05:07:13Z">
  <state datetime="2021-07-13">REFERRED</state>
  <status>
    <introduced datetime="2021-07-13"/>
  </status>
  <introduced datetime="2021-07-13"/>
  <titles>
    <title type="official" as="introduced">To amend title XI of the Social Security Act to provide for drug manufacturer price transparency.</title>
    <title type="display">SPIKE Act</title>
    <title type="short" as="introduced">SPIKE Act</title>
    <title type="short" as="introduced">Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act</title>
  </titles>
  <sponsor bioguide_id="H001066"/>
  <cosponsors>
    <cosponsor bioguide_id="C001084" joined="2021-08-10"/>
    <cosponsor bioguide_id="H001085" joined="2021-08-10"/>
    <cosponsor bioguide_id="N000191" joined="2021-09-21"/>
    <cosponsor bioguide_id="N000147" joined="2021-07-13"/>
    <cosponsor bioguide_id="R000606" joined="2021-07-13"/>
    <cosponsor bioguide_id="S001208" joined="2021-08-10"/>
    <cosponsor bioguide_id="S001209" joined="2021-07-13"/>
  </cosponsors>
  <actions>
    <action datetime="2021-07-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-07-13" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-07-13">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-07-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-07-14">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2021-08-17T23:48:39Z" status="Introduced in House">Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.</summary>
</bill>
